+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 85Years
All Genders
Healthy Volunteers
ID06513208

Study of IV Ketorolac Versus Placebo for Pain Relief After One or Two Level Lumbar Spinal Fusion Surgery

Led by University of Maryland St. Joseph Medical Center · Updated on 2025-12-22

140

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a double-blind, randomized trial to evaluate the effects of intravenous ketorolac compared to a placebo in managing pain for patients undergoing one or two level lumbar spinal fusions. The study aims to understand whether ketorolac can reduce post-operative opioid use and improve recovery outcomes without affecting spinal fusion success. Participants will receive either IV ketorolac at a dose of 15 mg every 6 hours for four doses or an IV saline placebo during the first 48 hours after surgery. The study includes two groups the ketorolac treatment arm and the placebo control arm. This design allows comparison of pain management, opioid use, and hospital stay length between the two groups. During the study, researchers will measure total opioid use during inpatient stay, spinal fusion success assessed by specific x-rays at 6 and 12 months, and the average length of hospital stay. Participants will be followed for 12 months to monitor these outcomes. The study will also require consent, language proficiency, and adherence to follow-up visits to ensure complete data collection and safety monitoring.

CONDITIONS

Brief Title

Ketorolac Effects on Post-operative Pain and Lumbar Fusion

Research Team

A

Aja Janyavula

S

Sam Rudow

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here